Research map: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers · Giovanni Tossetta · 2023 · 79 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. A Multiple Testing Procedure for Clinical Trials · Peter C. O’Brien · 1979 · 3371 citations · Cited by this paper
  5. Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations · Xiang Chen · 2023 · 78 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study · Aurélien Marabelle · 2019 · 3081 citations · Cited by this paper
  8. Active Ingredients from Chinese Medicine for Combination Cancer Therapy · Xuan Wang · 2023 · 53 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma · Nicole Concin · 2020 · 2015 citations · Cited by this paper
  11. Role of natural products in tumor therapy from basic research and clinical perspectives · Zhisen Wang · 2024 · 47 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. RECIST 1.1—Update and clarification: From the RECIST committee · Lawrence Howard Schwartz · 2016 · 1949 citations · Cited by this paper
  14. An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments · Nunzio Antonio Cacciola · 2023 · 47 citations · Cites this paper
  15. Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group · 2025 · Related
  16. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma · Robert John Motzer · 2021 · 1811 citations · Cited by this paper
  17. Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I) · Szu‐Ting Yang · 2024 · 34 citations · Cites this paper
  18. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  19. Proton pump inhibitors affect the gut microbiome · Floris Imhann · 2015 · 1377 citations · Cited by this paper
  20. Top Ten Lessons Learned from Trials in Oligometastatic Cancers · Vivian S. Tan · 2022 · 29 citations · Cites this paper
  21. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  22. Radiotherapy induces responses of lung cancer to CTLA-4 blockade · Silvia Chiara Formenti · 2018 · 951 citations · Cited by this paper
  23. Advances in autophagy modulation of natural products in cervical cancer · Tao Tao · 2023 · 29 citations · Cites this paper
  24. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  25. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials · Willemijn S.M.E. Theelen · 2020 · 580 citations · Cited by this paper
  26. First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial · Alex De Caluwé · 2023 · 26 citations · Cites this paper
  27. Tumor Immune Regulation by Natural Products: Mechanistic Insights and Therapeutic Potential · 2026 · Related
  28. Survival with Cemiplimab in Recurrent Cervical Cancer · Krishnansu S. Tewari · 2022 · 458 citations · Cited by this paper
  29. Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease · Alf Spitschak · 2022 · 19 citations · Cites this paper
  30. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy · Fernanda G. Herrera · 2021 · 454 citations · Cited by this paper
  31. The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer · Euclides Avila · 2023 · 18 citations · Cites this paper
  32. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment · Emiel A. De Jaeghere · 2019 · 161 citations · Cited by this paper
  33. Enhancing cancer immunotherapy using cordycepin and Cordyceps militaris extract to sensitize cancer cells and modulate immune responses · Chutamas Thepmalee · 2024 · 16 citations · Cites this paper
  34. Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC). · Hans J. Hammers · 2020 · 88 citations · Cited by this paper
  35. Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities · Changjing Cai · 2025 · 16 citations · Cites this paper
  36. Untitled · Cited by this paper
  37. Immune microenvironment and molecular mechanisms in endometrial cancer: implications for resistance and innovative treatments · Yijia Chen · 2025 · 15 citations · Cites this paper
  38. Untitled · Cited by this paper
  39. Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges · Anna Gajos-Michniewicz · 2024 · 14 citations · Cites this paper

Source: OpenAlex (CC0)